OliX PharmaceuticalsI Valuation
| 226950 Stock | 19,620 630.00 3.11% |
At this time, the company appears to be overvalued. OliX PharmaceuticalsInc holds a recent Real Value of USD18286.8 per share. The prevailing price of the company is USD19620.0. Our model determines the value of OliX PharmaceuticalsInc from analyzing the company fundamentals such as Return On Equity of -76.63, shares owned by insiders of 29.21 %, and Current Valuation of 576.53 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that OliX PharmaceuticalsI's price fluctuation is very steady at this time. Calculation of the real value of OliX PharmaceuticalsInc is based on 3 months time horizon. Increasing OliX PharmaceuticalsI's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OliX PharmaceuticalsI is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OliX Stock. However, OliX PharmaceuticalsI's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19620.0 | Real 18286.8 | Hype 19620.0 |
The real value of OliX Stock, also known as its intrinsic value, is the underlying worth of OliX PharmaceuticalsInc Company, which is reflected in its stock price. It is based on OliX PharmaceuticalsI's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of OliX PharmaceuticalsI's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of OliX PharmaceuticalsInc helps investors to forecast how OliX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OliX PharmaceuticalsI more accurately as focusing exclusively on OliX PharmaceuticalsI's fundamentals will not take into account other important factors: OliX PharmaceuticalsI Total Value Analysis
OliX PharmaceuticalsInc is presently forecasted to have takeover price of 576.53 B with market capitalization of 152.89 B, debt of 20.38 B, and cash on hands of 34.34 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the OliX PharmaceuticalsI fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
576.53 B | 152.89 B | 20.38 B | 34.34 B |
OliX PharmaceuticalsI Investor Information
About 29.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. OliX PharmaceuticalsInc had 2:1 split on the 3rd of December 2020. OliX PharmaceuticalsInc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.OliX PharmaceuticalsI Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. OliX PharmaceuticalsI has an asset utilization ratio of 4.24 percent. This suggests that the Company is making USD0.0424 for each dollar of assets. An increasing asset utilization means that OliX PharmaceuticalsInc is more efficient with each dollar of assets it utilizes for everyday operations.OliX PharmaceuticalsI Ownership Allocation
The market capitalization of OliX PharmaceuticalsInc is USD152.89 Billion. OliX PharmaceuticalsI has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.OliX PharmaceuticalsI Profitability Analysis
The company reported the revenue of 3.67 B. Net Loss for the year was (30.28 B) with profit before overhead, payroll, taxes, and interest of 2.42 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates OliX PharmaceuticalsI's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in OliX PharmaceuticalsI and how it compares across the competition.
About OliX PharmaceuticalsI Valuation
The stock valuation mechanism determines OliX PharmaceuticalsI's current worth on a weekly basis. Our valuation model uses a comparative analysis of OliX PharmaceuticalsI. We calculate exposure to OliX PharmaceuticalsI's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OliX PharmaceuticalsI's related companies.8 Steps to conduct OliX PharmaceuticalsI's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OliX PharmaceuticalsI's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OliX PharmaceuticalsI's valuation analysis, follow these 8 steps:- Gather financial information: Obtain OliX PharmaceuticalsI's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine OliX PharmaceuticalsI's revenue streams: Identify OliX PharmaceuticalsI's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research OliX PharmaceuticalsI's industry and market trends, including the size of the market, growth rate, and competition.
- Establish OliX PharmaceuticalsI's growth potential: Evaluate OliX PharmaceuticalsI's management, business model, and growth potential.
- Determine OliX PharmaceuticalsI's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OliX PharmaceuticalsI's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for OliX Stock analysis
When running OliX PharmaceuticalsI's price analysis, check to measure OliX PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OliX PharmaceuticalsI is operating at the current time. Most of OliX PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of OliX PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OliX PharmaceuticalsI's price. Additionally, you may evaluate how the addition of OliX PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |